Switzerland
Dr. Behrooz Kasraee is a renowned physician dermatologist and researcher whose passion for skin pigmentation concerns has led him to become one of the leaders in this field of study. Not only is he the only person to successfully find a way to stabilize cysteamine, but he also runs one of the most successful vitiligo clinics in the world. He identified a series of new skin depigmenting agents such as methimazole, ebselen and isoniazide. Dr. Kasraee has set forth the concept of H2O2-mediated melanin synthesis and its role as a defence mechanism against oxidative stress. He is at the origin of novel in vitro methods for melanosomal transfer measurement. Behrooz, MD, was instrumental in developing the new pigment corrector formulated with cysteamine. Dr. Kasraee is founder & chairman of Scientis & Swiss Vitiligo Center.